Flagship Ventures Fund IV, L.P., 10% Owner at Syros Pharmaceuticals, Inc. (SYRS), bought 400,000 shares at $12.50 ($5.0M) on 2016-07-06, disclosed to the SEC on 2016-07-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 80,000 | $1.0M | 20.0% |
| 2 | $12.50 | 320,000 | $4.0M | 80.0% |
| Total | $12.50 avg | 400,000 | $5.0M | 100% |